This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Stephens, R. C.M. Articles by Bennett-Guerrero, E. Search for Related Content PubMed PubMed Citation Articles by Stephens, R. C.M. Articles by Bennett-Guerrero, E. Social Bookmarking                   What's this?

Low-dose endotoxin elicits variability in the inflammatory response in healthy volunteers

Portex Anaesthesia, Intensive Therapy and Respiratory Unit, Institute of Child Health, London, UK, r.stephens{at}ich.ucl.ac.uk

Catherine M.N. O'Malley

Department of Anaesthesia, St James's Hospital, Dublin, Ireland

Robert J. Frumento

Department of Anesthesiology, Division of Cardiothoracic Anesthesia, Columbia University College of Physicians & Surgeons, New York, USA

Michael G. Mythen

Portex Anaesthesia, Intensive Therapy and Respiratory Unit, Institute of Child Health, London, UK

Elliott Bennett-Guerrero

Department of Anesthesiology, Duke University Medical Centre, Durham, North Carolina, USA

Endotoxin has been implicated as a cause of sepsis, inflammation and organ dysfunction after surgery. Patients differ in their response to endotoxin, and this may account for differences in outcome. The traditional human model of endotoxin challenge (2—4 ng/kg) is not associated with significant inter-individual variability in systemic inflammation and may not be suitable for studying variability in the inflammatory response. We examined whether low-dose regimens of endotoxin cause significant variability in inflammation. Volunteers (n = 30) were randomised in a double-blinded (`double-dummy') study to one of 6 dosing regimens: saline (placebo) or Escherichia coli O:113 endotoxin as a 4 ng/kg bolus (positive control), 0.25 ng/kg (bolus), 0.25 ng/kg (30 min infusion), 0.75 ng/kg (bolus) or 0.75 ng/kg (30 min infusion). Temperature, white cell count, platelet count, C-reactive protein and cytokine changes from baseline were measured. In contrast to subjects receiving placebo, those randomised to 4 ng/kg endotoxin exhibited significant systemic inflammation during the 10-h observation period. The four low-dose regimens elicited variability in most markers of inflammation. We conclude that low-dose endotoxin elicits inter-individual variability in inflammation and could be used to test factors that may affect the human response to endotoxin.

Key Words: Endotoxin • human • inflammation • lipopolysaccharide • volunteer

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?